Olema Pharmaceuticals Inc...

4.21
-0.16 (-3.66%)
At close: Mar 03, 2025, 3:59 PM
4.25
0.83%
After-hours: Mar 03, 2025, 06:01 PM EST

Olema Pharmaceuticals Ratios Statement

Year FY23 FY22 FY21 FY20 FY19 FY18
PE Ratio -6.57 -0.96 -5.22 -83.03 -456.05 -314.44
PEG Ratio 0.40 -0.02 -0.03 -0.19 14.59 n/a
PS Ratio n/a n/a n/a n/a n/a n/a
PB Ratio 2.50 0.50 1.30 5.59 -185.8 -110.04
P/FCF Ratio -7.58 -1.19 -7.08 -94.87 -638.86 -317.48
P/OCF Ratio -7.58 -1.19 -7.3 -95.13 -638.86 -317.48
OCF/S Ratio n/a n/a n/a n/a n/a n/a
Debt / Equity Ratio 0.01 0.01 0.01 n/a n/a n/a
Quick Ratio 12.33 12.64 31.89 74.62 0.07 16.13
Current Ratio 12.33 12.62 31.85 74.62 0.07 16.13
Asset Turnover n/a n/a n/a n/a n/a n/a
Interest Coverage n/a n/a n/a -32.97 n/a -74.25
Return on Equity (ROE) -0.38 -0.52 -0.25 -0.07 0.41 0.35
Return on Assets (ROA) -0.35 -0.48 -0.24 -0.07 -32.7 -0.67
Return on Capital (ROIC) -0.41 -0.54 -0.25 -0.06 3.47 -0.68
Dividend Yield n/a n/a n/a n/a n/a n/a
Payout Ratio n/a n/a n/a n/a n/a n/a
Gross Profit Margin n/a n/a n/a n/a n/a n/a
Net Profit Margin n/a n/a n/a n/a n/a n/a
Pretax Profit Margin n/a n/a n/a n/a n/a n/a
Operating Profit Margin n/a n/a n/a n/a n/a n/a
FCF Margin n/a n/a n/a n/a n/a n/a
EBITDA Margin n/a n/a n/a n/a n/a n/a